Mauritius vs Sur: HIV-positive TB patients on ART (antiretroviral therapy)
Mauritius
100.0%
in 2024
Sur
82.0%
in 2024
Mauritius rank
1st
Sur rank
2nd
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Mauritius
- Sur
How they compare
Mauritius currently reports 100.0% against 82.0% in Sur, a difference of 18.0%.
That makes Mauritius's figure about 1.2 times Sur's.
The two have swapped places 2 times across 19 shared years of data; in 2003 it was Mauritius ahead.
Mauritius ranks 1st and Sur ranks 2nd of 144 countries.
Mauritius has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Mauritius | Sur | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 59.5% | 27.5% | 32.0% | Mauritius |
| 2010s | 86.2% | 66.3% | 19.9% | Mauritius |
| 2020s | 100.0% | 75.8% | 24.2% | Mauritius |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Mauritius or Sur?
- Mauritius, at 100.0% against 82.0% in Sur as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Mauritius and Sur?
- 18.0%, with Mauritius ahead.
- How many years of comparable data are there for Mauritius and Sur?
- 19 years are reported by both, from 2003 to 2024.
- How do Mauritius and Sur rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Mauritius ranks 1st and Sur ranks 2nd of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.